Last updated: June 4, 2026
Litigation summary and analysis: Fresenius Medical Care Holdings (FMC) v. Paddock Laboratories, 1:09-cv-11130
Executive summary
Fresenius Medical Care Holdings, Inc. (FMC) sued Paddock Laboratories, Inc. in the District of Massachusetts for patent infringement tied to FMC’s dialysis-related product technology. The case is docketed as 1:09-cv-11130. The available record provided here does not include the operative pleadings, asserted patents, claim constructions, Markman rulings, judgment, settlement terms, or appellate posture. Without those case-specific filings and disposition documents, a complete and accurate infringement and validity/indirect infringement analysis cannot be produced.
What patents were asserted in FMC v. Paddock Laboratories 1:09-cv-11130?
Answer: Not determinable from the information provided.
Asserted patent set and claims
Answer: Not determinable from the information provided.
Patent numbers, expiration dates, and assignees
Answer: Not determinable from the information provided.
What did FMC allege Paddock infringed in 1:09-cv-11130?
Answer: Not determinable from the information provided.
Product and technology scope
Answer: Not determinable from the information provided.
Infringement theory (direct, induced, willful)
Answer: Not determinable from the information provided.
What defenses did Paddock raise in the infringement case 1:09-cv-11130?
Answer: Not determinable from the information provided.
Invalidity and unenforceability defenses
Answer: Not determinable from the information provided.
Non-infringement and claim construction positions
Answer: Not determinable from the information provided.
How did the court handle claim construction or Daubert-type disputes in 1:09-cv-11130?
Answer: Not determinable from the information provided.
Markman outcomes
Answer: Not determinable from the information provided.
Summary judgment posture
Answer: Not determinable from the information provided.
What was the final case outcome for 1:09-cv-11130?
Answer: Not determinable from the information provided.
Judgment type and date
Answer: Not determinable from the information provided.
Injunction, royalty, or damages ruling
Answer: Not determinable from the information provided.
Was there a settlement or consent judgment in 1:09-cv-11130?
Answer: Not determinable from the information provided.
Settlement agreement terms that matter for IP strategy
Answer: Not determinable from the information provided.
What is the litigation timeline for FMC v. Paddock 1:09-cv-11130?
Answer: Not determinable from the information provided.
Key milestones
Answer: Not determinable from the information provided.
How does this case affect FMC’s patent estate and freedom to operate?
Answer: Not determinable from the information provided.
Practical impact on competitive launches
Answer: Not determinable from the information provided.
How does this case compare with other FMC dialysis-related patent litigations?
Answer: Not determinable from the information provided.
Cross-case learnings (claims, venues, outcomes)
Answer: Not determinable from the information provided.
Key Takeaways
No litigation summary or legal analysis can be completed from the docket identifier alone. A reliable infringement and validity assessment requires the asserted patents, FMC’s infringement allegations, Paddock’s defenses, claim construction, and the final disposition, none of which are included in the information provided.
FAQs
1) Which patents does FMC rely on in 1:09-cv-11130?
Not determinable from the information provided.
2) Did the court construe any disputed claim terms?
Not determinable from the information provided.
3) Did Paddock file a counterclaim for invalidity or unenforceability?
Not determinable from the information provided.
4) Was there an injunction or final damages award?
Not determinable from the information provided.
5) How did the case end and were there appeals?
Not determinable from the information provided.
